The main issue was whether the lis pendens rules in Articles 29–31 of the Brussels I Regulation (Regulation (EU) No 1215/2012, recast) apply to determine the relationship between the German revocation and UPC revocation proceedings. Mala argued these rules should...
The matter started when Amgen sued various Sanofi companies and Regeneron for patent infringement of their EP3666797 patent. The patent claims an antibody that binds to the catalytic domain of a PCSK9 protein and its use in treating or preventing...
Background to the UPC The European Unitary Patent is intended to provide a further and more efficient option for enforcement of patent rights across the European Union. It is based on the European patent system which is overseen by the European Patent Organisation...
Recent Comments